Evidence map›Paper›PMID 32940861›Full record

ReviewNeurochemical research2020

Novel Neuroprotective Potential of Crocin in Neurodegenerative Disorders: An Illustrated Mechanistic Review.

Sareh Kermanshahi, Ghazal Ghanavati, Mobina Abbasi-Mesrabadi, Mina Gholami, Luis Ulloa, Majid Motaghinejad, Sepideh Safari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Enhancing Neuroprotection Through Exercise: The Synergistic Effects of Bioactive Plant Compounds Via the CREB-BDNF Signaling Pathway.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sareh KermanshahiRazi Drug Research Center, Iran University of Medical Sciences, Hemmat highway, Beside the Milad Tower, P.O. Box: 14496-14525, Tehran, Iran.
Ghazal GhanavatiRazi Drug Research Center, Iran University of Medical Sciences, Hemmat highway, Beside the Milad Tower, P.O. Box: 14496-14525, Tehran, Iran.
Mobina Abbasi-MesrabadiRazi Drug Research Center, Iran University of Medical Sciences, Hemmat highway, Beside the Milad Tower, P.O. Box: 14496-14525, Tehran, Iran.
Mina GholamiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Luis UlloaCenter for Perioperative Organ Protection, Department of Anesthesiology, Duke University, Durham, NC, USA. luis.ulloa@duke.edu.
Majid MotaghinejadRazi Drug Research Center, Iran University of Medical Sciences, Hemmat highway, Beside the Milad Tower, P.O. Box: 14496-14525, Tehran, Iran. Motaghinezhad.m@iums.ac.ir.
Sepideh SafariRazi Drug Research Center, Iran University of Medical Sciences, Hemmat highway, Beside the Milad Tower, P.O. Box: 14496-14525, Tehran, Iran.
Milad Hospital · IRIran University of Medical Sciences · IRDuke University · USTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative disorders are characterized by mitochondrial dysfunction and subsequently oxidative stress, inflammation, and apoptosis that contribute to neuronal cytotoxicity and degeneration. Recent studies reported that crocin, a carotenoid chemical compound common in crocus and gardenia flowers, has protective effects in neurodegenerative disorders due to its anti-oxidative, anti-inflammatory, and anti-apoptotic properties in the nervous system. This article reviews the new experimental, clinical, and pharmacological studies on the neuroprotective properties of crocin and its potential mechanisms to modulate metabolic oxidative stress and inflammation in neurodegenerative disorders.

Indexed as

AnimalsAnti-Inflammatory AgentsApoptosisCarotenoidsHumansInflammationNeurodegenerative DiseasesNeuroprotective AgentsOxidative StressAnti-Inflammatory AgentsCarotenoidscrocinNeuroprotective AgentsApoptosisCrocinInflammationMitochondrial dysfunctionNeurodegenerationOxidative stress

Identifiers

PMID32940861
OpenAlexW3084998057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.